Glioblastoma Multiforme

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients

Published February 9, 2010, 1:09 am, PharmaceuticalOnline

Pfizer Inc. and DxS (a wholly owned subsidiary of QIAGEN N.V.) (Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM).

Discover News | Full Story


Astrocytoma (Brain Tumor, Glioma)

Published February 8, 2010, 7:39 pm, ThirdAge

Astrocytoma is a malignant, or cancerous, type of brain tumor. This type of tumor arises from small, star-shaped cells in the brain called astrocytes. Astrocytes are one of several types of supporting cells in the brain called glial cells.

Discover News | Full Story


08.02.2010 - PRESS RELEASE: QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results

Published February 8, 2010, 1:54 pm, 4investors

Qiagen N.V. / QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.

Discover News | Full Story


QIAGEN Reports Strong Fourth Quarter and Fiscal 2009 Results

Published February 8, 2010, 1:00 pm, GlobeNewswire via Yahoo! Finance

VENLO, Netherlands -- QIAGEN N.V. today announced the results of operations for the fourth quarter and the fiscal year ended December 31, 2009.

Discover News | Full Story


Qiagen, Pfizer to Develop Companion Diagnostic for Brain Tumors

Published February 8, 2010, 7:24 am, Medical Device Link

Pfizer Inc. and DxS, a wholly owned subsidiary of Qiagen N.V. have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial terms of the diagnostic agreement have not been disclosed.

Discover News | Full Story


Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Record

Published February 8, 2010, 7:15 am, PR Newswire via Yahoo! Finance

Northwest Biotherapeutics, Inc. , a development stage biotechnology company focused on personalized cancer vaccines to enhance immune system responses to tumors, has retained Market Media Connect as their communications agency of record. Â Led from its Los Angeles headquarters, Market Media Connect will support Northwestâs communication objectives as the company moves into the next phase of its ...

Discover News | Full Story


Brave Rosebud mum pleads for help to beat cancer

Published February 7, 2010, 9:33 pm, Leader Community Newspapers

A YOUNG mum is called on the public to help her beat a deadly brain tumour.

Discover News | Full Story


Jury to hear of other cancers

Published February 6, 2010, 11:31 pm, Northwest Herald

A Pennsylvania judge denied a motion by Rohm and Haas to forbid mention of other McCullom Lake brain cancers in its upcoming trial on behalf of one of the first plaintiffs.

Discover News | Full Story


QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients

Published February 6, 2010, 5:18 am, Medical News Today

Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial terms of the diagnostic agreement have not been ...

Discover News | Full Story


Pfizer, DxS enter pact to develop companion diagnostic test kit for brain tumour patients

Published February 5, 2010, 9:36 pm, PharmaBiz

Pfizer Inc. and DxS (a wholly owned subsidiary of Qiagen N.V.) announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial terms of the diagnostic agreement have not been disclosed.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a